M&A Deal Summary

Boston Scientific Acquires BTG

On November 20, 2018, Boston Scientific acquired medical products company BTG for 4.2B USD

Acquisition Highlights
  • This is Boston Scientific’s 38th transaction in the Medical Products sector.
  • This is Boston Scientific’s 2nd largest (disclosed) transaction.
  • This is Boston Scientific’s 2nd transaction in the United Kingdom.

M&A Deal Summary
Date 2018-11-20
Target BTG
Sector Medical Products
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition
Deal Value 4.2B USD
Advisor(s) Allen & Overy (Legal)

Target

BTG

London, United Kingdom
BTG plc which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals. BTG has three key businesses, the largest of which is its Interventional Medicine portfolio which encompasses several peripheral interventional product lines. The interventional oncology franchise includes the TheraSphere® Y-90 radiotherapy microspheres and the GALIL™ cryoablation system, used to treat patients with liver, kidney, and other cancers. More than 840,000 people are expected to be diagnosed with liver cancer in 2018, and that number is expected to grow to 1.1 million by 2030. Kidney cancer is among the 10 most common cancers in both men and women.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States
Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 14.2B USD (2023)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 52 of 66
Sector (Medical Products) 38 of 50
Type (Add-on Acquisition) 41 of 51
Country (United Kingdom) 2 of 2
Year (2018) 10 of 10
Size (of disclosed) 2 of 34
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-06 Augmenix

Bedford, Massachusetts, United States

Augmenix, Inc. is a developer and commercialized the SpaceOAR® System, a therapy used to reduce common and debilitating side effects that men may experience after receiving prostate cancer radiotherapy. Augmenix was founded in 2008 and is based in Bedford, Massachusetts.

Buy $500M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-09 Vertiflex

San Clemente, California, United States

Vertiflex, Inc. is a privately held medical device company dedicated to the advancement of minimally invasive solutions for the treatment of lumbar spinal stenosis(LSS). Vertiflex was founded in 2004 and is based in San Clemente, California.

Buy $465M
Mergr

Product

Company

Legal